MedPath

A lifestyle intervention program for the prevention of type 2 diabetes mellitus among South Asian women with gestational diabetes mellitus

Not Applicable
Conditions
Gestational Diabetes
Registration Number
SLCTR/2017/001
Lead Sponsor
Dr. Anushka Patel
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow up complete
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Absence of type 2 diabetes mellitus (T2DM) as confirmed by findings of Impaired Glucose Tolerance, Impaired Fasting Glucose, Normal Glucose Tolerance at the at 6±3 months post-partum OGTT (Oral Glucose Tolerance Test)

Exclusion Criteria

1. Place of residence outside the catchment of the treating hospital
2. Lack of access to a mobile telephone

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Proportion of women with a change of glycaemic category, at or prior to final visit:<br><br>• Normal glucose tolerance to impaired fasting glucose (IFG) or impaired glucose tolerance (IGT) or T2DM<br><br><br>• IFG or IGT to T2DM<br> [At baseline and at the final visit.<br>(The median follow up period of the study is 24 months and minimum follow up is 12 months.The end of study visit would be different for each participant depending on when they are randomized)<br>]<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath